| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 71335-0091-8 | 71335-0091 | HUMAN PRESCRIPTION DRUG | Benzonatate | Benzonatate | CAPSULE | ORAL | 20190430 | N/A | ANDA | ANDA040597 | Bryant Ranch Prepack | BENZONATATE | 100 mg/1 | 14 CAPSULE in 1 BOTTLE (71335-0091-8) |
| 71335-0091-9 | 71335-0091 | HUMAN PRESCRIPTION DRUG | Benzonatate | Benzonatate | CAPSULE | ORAL | 20190430 | N/A | ANDA | ANDA040597 | Bryant Ranch Prepack | BENZONATATE | 100 mg/1 | 40 CAPSULE in 1 BOTTLE (71335-0091-9) |
| 50090-6387-1 | 50090-6387 | HUMAN PRESCRIPTION DRUG | Benzonatate | Benzonatate | CAPSULE | ORAL | 20230308 | N/A | ANDA | ANDA040597 | A-S Medication Solutions | BENZONATATE | 100 mg/1 | 24 CAPSULE in 1 BOTTLE (50090-6387-1) |
| 50090-6387-2 | 50090-6387 | HUMAN PRESCRIPTION DRUG | Benzonatate | Benzonatate | CAPSULE | ORAL | 20230308 | N/A | ANDA | ANDA040597 | A-S Medication Solutions | BENZONATATE | 100 mg/1 | 30 CAPSULE in 1 BOTTLE (50090-6387-2) |
| 50090-6387-5 | 50090-6387 | HUMAN PRESCRIPTION DRUG | Benzonatate | Benzonatate | CAPSULE | ORAL | 20230308 | N/A | ANDA | ANDA040597 | A-S Medication Solutions | BENZONATATE | 100 mg/1 | 15 CAPSULE in 1 BOTTLE (50090-6387-5) |
| 50090-6387-0 | 50090-6387 | HUMAN PRESCRIPTION DRUG | Benzonatate | Benzonatate | CAPSULE | ORAL | 20230308 | N/A | ANDA | ANDA040597 | A-S Medication Solutions | BENZONATATE | 100 mg/1 | 20 CAPSULE in 1 BOTTLE (50090-6387-0) |